TCL Archive DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan June 10, 1988
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014